DE69937369D1 - CCR5 Antikörper PA14 - Google Patents

CCR5 Antikörper PA14

Info

Publication number
DE69937369D1
DE69937369D1 DE69937369T DE69937369T DE69937369D1 DE 69937369 D1 DE69937369 D1 DE 69937369D1 DE 69937369 T DE69937369 T DE 69937369T DE 69937369 T DE69937369 T DE 69937369T DE 69937369 D1 DE69937369 D1 DE 69937369D1
Authority
DE
Germany
Prior art keywords
monoclonal antibody
binds
fragment
antibody
ccr5 antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937369T
Other languages
English (en)
Other versions
DE69937369T2 (de
Inventor
William C Olson
Paul J Maddon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenics Pharmaceuticals Inc
Original Assignee
Progenics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharmaceuticals Inc filed Critical Progenics Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69937369D1 publication Critical patent/DE69937369D1/de
Publication of DE69937369T2 publication Critical patent/DE69937369T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69937369T 1998-12-16 1999-12-16 CCR5 Antikörper PA14 Expired - Lifetime DE69937369T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21279398A 1998-12-16 1998-12-16
US11253298P 1998-12-16 1998-12-16
US212793 1998-12-16
PCT/US1999/030345 WO2000035409A2 (en) 1998-12-16 1999-12-16 Hiv-i fusion inhibition compounds
US112532P 2008-11-07

Publications (2)

Publication Number Publication Date
DE69937369D1 true DE69937369D1 (de) 2007-11-29
DE69937369T2 DE69937369T2 (de) 2008-07-24

Family

ID=26810060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937369T Expired - Lifetime DE69937369T2 (de) 1998-12-16 1999-12-16 CCR5 Antikörper PA14

Country Status (13)

Country Link
EP (2) EP2088158A3 (de)
JP (1) JP2002538771A (de)
AT (1) ATE375802T1 (de)
AU (3) AU773175B2 (de)
CA (1) CA2355607A1 (de)
CY (1) CY1107858T1 (de)
DE (1) DE69937369T2 (de)
DK (1) DK1144006T3 (de)
ES (1) ES2296416T3 (de)
HK (1) HK1041207B (de)
MX (1) MXPA01006097A (de)
PT (1) PT1144006E (de)
WO (1) WO2000035409A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2325042T3 (es) 1995-06-07 2009-08-24 Progenics Pharmaceuticals, Inc. Anticuerpo monoclonal para inhibir la fusion de membrana mediada por glicoproteina de la envoltura de vih-1.
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2265701A (en) * 1999-12-16 2001-06-25 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
US7138119B2 (en) 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20020146415A1 (en) * 2001-04-06 2002-10-10 Olson William C. Methods for inhibiting HIV-1 infection
DE60203324T2 (de) * 2001-12-21 2006-04-06 Micromet Ag Einzelne und duale anti-cd4-rantes chemokin/zytokin konstrukte
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
RU2322454C2 (ru) * 2002-02-22 2008-04-20 Проджиникс Фармасьютикалз, Инк. Антитело против ccr5
TW200720289A (en) 2005-04-01 2007-06-01 Hoffmann La Roche Antibodies against CCR5 and uses thereof
EP1981911A2 (de) * 2006-01-30 2008-10-22 F.Hoffmann-La Roche Ag Synergistische zusammensetzungen zur hiv-behandlung
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
JP2010500984A (ja) 2006-08-17 2010-01-14 エフ．ホフマン−ラ ロシュ アーゲー Ｃｃｒ５に対する抗体と抗膜融合ペプチドとの抱合体
EP2074147B1 (de) 2006-09-29 2012-03-21 F. Hoffmann-La Roche AG Antikörper gegen ccr5 und ihre verwendung
CL2008000707A1 (es) 2007-03-13 2008-09-22 Hoffmann La Roche Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045543A2 (en) * 1996-05-28 1997-12-04 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health Cc chemokine receptor 5, antibodies thereto, transgenic animals
CA2257991A1 (en) * 1996-06-14 1997-12-18 Progenics Pharmaceuticals, Inc. Uses of a chemokine receptor for inhibiting hiv-1 infection
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
CY1107858T1 (el) 2013-06-19
DE69937369T2 (de) 2008-07-24
EP2088158A3 (de) 2010-01-20
AU2004205165A1 (en) 2004-09-16
CA2355607A1 (en) 2000-06-22
JP2002538771A (ja) 2002-11-19
EP1144006A2 (de) 2001-10-17
WO2000035409A3 (en) 2000-09-14
PT1144006E (pt) 2007-12-11
EP1144006B1 (de) 2007-10-17
EP1144006A4 (de) 2004-11-24
HK1041207B (zh) 2007-12-28
ES2296416T3 (es) 2008-04-16
AU2199600A (en) 2000-07-03
WO2000035409A2 (en) 2000-06-22
EP2088158A2 (de) 2009-08-12
AU2004205164A1 (en) 2004-09-16
DK1144006T3 (da) 2007-11-26
ATE375802T1 (de) 2007-11-15
HK1041207A1 (en) 2002-07-05
AU773175B2 (en) 2004-05-20
MXPA01006097A (es) 2002-04-15

Similar Documents

Publication Publication Date Title
CY1107858T1 (el) Ccr5 αντισωματα pa14
NZ616992A (en) Anti-ilt7 antibody
ATE208820T1 (de) Humanisierte antikoerper
IL226637A0 (en) An isolated heterodimeric cytokine receptor
ATE324381T1 (de) Mutiertes scfv-fragment des okt-3 antikörpers
NZ712762A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
DE69630313D1 (de) Mit monoklonalem antikörper anti-her2 induzierte apoptosis
CA2221893A1 (fr) Anticorps specifique de staphylococcus aureus et utilisations
HK1115607A1 (en) Human cytokine receptor
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
DE60014124D1 (de) Antikörper, die spezifisch für fullerene sind
FI873410A0 (fi) Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
MX9702422A (es) Anticuerpos recombinantes contra fas y adn para los mismos.
ES2114547T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c.
DE59410219D1 (de) Monoklonale antikörper gegen ck-mb
SI1396501T1 (sl) Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr
BR0007827A (pt) Anticorpos e fragmento fv que reconhecemantìgeno ior c2
KR890701630A (ko) 인간 t세포 표면 수용기들 중 감마 사슬의 에피토프를 인지하는 단일 클론 항체
EP0265156A3 (de) Monoklonale Antikörper
EP0349258A3 (de) Verfahren zur Bestimmung der Differenzierung einer menschlichen T-Zelle
SE9501302D0 (sv) Antibodies for use in cancertherapy and diagnosis
KR960023044A (ko) 재조합 인간 에리스로포이에틴에 대한 단일클론항체 및 이를 생산하는 신규의 융합세포주
UA39209C2 (uk) Моноклональне антитіло, що інгібує хомінг кровотворних стовбурових клітин і розпізнає поверхневий антіген стромальної клітини селезінки, гібридома, яка його продукує

Legal Events

Date Code Title Description
8364 No opposition during term of opposition